Legal & General Group PLC Catalent, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Catalent, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 1,116,749 shares of CTLT stock, worth $66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,116,749

Previous 1,116,749 -0.0%

Holding current value

$66 Million

Previous $67.6 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $3.48 Million - $3.77 Million	61,883 Added 5.87%	1,116,749 $67.6 Million
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $2.72 Million - $2.9 Million	-50,834 Reduced 4.6%	1,054,866 $59.3 Million
Q1 2024 Jul 01, 2024	BUY	$42.56 - $59.82 $929,212 - $1.31 Million	21,833 Added 2.01%	1,105,700 $62.4 Million
Q1 2024 May 14, 2024	SELL	$42.56 - $59.82 $4.15 Million - $5.84 Million	-97,617 Reduced 8.26%	1,083,867 $61.2 Million
Q4 2023 Feb 15, 2024	BUY	$32.18 - $46.57 $1.2 Million - $1.73 Million	37,207 Added 3.25%	1,181,484 $53.1 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $1.42 Million - $1.61 Million	32,170 Added 2.89%	1,144,277 $52.1 Million
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $2 Million - $4.23 Million	-62,838 Reduced 5.35%	1,112,107 $48.2 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $897,258 - $1.47 Million	19,746 Added 1.71%	1,174,945 $77.2 Million
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $1.13 Million - $2.22 Million	-27,410 Reduced 2.32%	1,155,199 $52 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $2.03 Million - $3.17 Million	-28,043 Reduced 2.32%	1,182,609 $85.6 Million
Q2 2022 Aug 22, 2022	BUY	$87.2 - $114.05 $3.04 Million - $3.97 Million	34,828 Added 2.96%	1,210,652 $130 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $7.34 Million - $9.7 Million	77,933 Added 7.1%	1,175,824 $130 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $6.15 Million - $7.15 Million	51,402 Added 4.91%	1,097,891 $141 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $560,806 - $731,251	5,137 Added 0.49%	1,046,489 $139 Million
Q2 2021 Aug 12, 2021	BUY	$100.34 - $115.69 $7.92 Million - $9.14 Million	78,963 Added 8.2%	1,041,352 $113 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $33.8 Million - $41.7 Million	332,716 Added 52.84%	962,389 $101 Million
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $2.36 Million - $2.89 Million	27,430 Added 4.55%	629,673 $65.5 Million
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $3.62 Million - $4.61 Million	-49,788 Reduced 7.64%	602,243 $51.6 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $19.1 Million - $31.4 Million	397,159 Added 155.83%	652,031 $47.8 Million
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $1.13 Million - $1.93 Million	30,633 Added 13.66%	254,872 $13.3 Million
Q4 2019 Feb 13, 2020	BUY	$47.06 - $56.64 $363,962 - $438,053	7,734 Added 3.57%	224,239 $12.6 Million
Q3 2019 Nov 13, 2019	BUY	$47.45 - $58.05 $846,460 - $1.04 Million	17,839 Added 8.98%	216,505 $10.3 Million
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $275,958 - $381,042	7,029 Added 3.67%	198,666 $10.8 Million
Q1 2019 May 15, 2019	BUY	$29.84 - $43.92 $367,509 - $540,918	12,316 Added 6.87%	191,637 $7.78 Million
Q4 2018 Feb 15, 2019	BUY	$29.95 - $46.34 $117,044 - $181,096	3,908 Added 2.23%	179,321 $5.59 Million
Q3 2018 Nov 20, 2018	BUY	$40.12 - $45.55 $433,777 - $492,486	10,812 Added 6.57%	175,413 $7.99 Million
Q2 2018 Aug 10, 2018	BUY	$38.72 - $42.52 $90,333 - $99,199	2,333 Added 1.44%	164,601 $6.9 Million
Q1 2018 May 17, 2018	BUY	$39.4 - $47.39 $851,867 - $1.02 Million	21,621 Added 15.37%	162,268 $6.66 Million
Q4 2017 Feb 13, 2018	BUY	$37.27 - $43.02 $5.24 Million - $6.05 Million	140,647	140,647 $5.78 Million

Others Institutions Holding CTLT

# of Institutions

512

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Catalent, Inc. Transaction History